Kyverna Therapeutics Inc.
(KYTX)
undefined
undefined%
At close: undefined
Cashflow (Annual)
Get detailed ratio statement breakdowns, uncovering price to
free cash flow ratio, price per earnings, and much more.
| Year | FY23 | FY22 | FY21 |
| Net Income | -60.37M | -28.89M | -26.35M |
| Depreciation & Amortization | 1.71M | 1.05M | 586.00K |
| Stock-Based Compensation | 2.22M | 929.00K | 7.25M |
| Other Working Capital | -659.00K | -7.03M | -5.66M |
| Other Non-Cash Items | 605.00K | 1.41M | 829.00K |
| Deferred Income Tax | - | - | - |
| Change in Working Capital | 3.42M | -10.33M | -4.49M |
| Operating Cash Flow | -52.41M | -36.11M | -22.16M |
| Capital Expenditures | -621.00K | -768.00K | -1.29M |
| Acquisitions | - | - | - |
| Purchase of Investments | -54.85M | -56.49M | - |
| Sales Maturities Of Investments | 46.68M | 43.17M | - |
| Other Investing Acitivies | - | -13.33M | - |
| Investing Cash Flow | -8.79M | -14.10M | -1.29M |
| Debt Repayment | -781.00K | -249.00K | -41.00K |
| Common Stock Repurchased | - | - | - |
| Dividend Paid | - | - | - |
| Other Financial Acitivies | 59.90M | 12.13M | 72.56M |
| Financial Cash Flow | 58.12M | 11.88M | 72.52M |
| Net Cash Flow | -3.08M | -38.33M | 49.08M |
| Free Cash Flow | -53.03M | -36.88M | -23.44M |